Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1748-717X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial ; volume:12 ; number:1 ; day:22 ; month:9 ; year:2017 ; pages:1-8 ; date:12.2017
Radiation oncology ; 12, Heft 1 (22.9.2017), 1-8, 12.2017

Keyword
Krebs
Onkologie

Creator
De Wolf, Katrien
Contributor
Rottey, Sylvie
Vermaelen, Karim
Decaestecker, Karel
Sundahl, Nora
De Lobel, Lizzy
Goetghebeur, Els
De Meerleer, Gert
Lumen, Nicolaas
Fonteyne, Valerie
De Maeseneer, Daan
Ost, Piet
SpringerLink (Online service)

DOI
10.1186/s13014-017-0893-x
URN
urn:nbn:de:1111-2017112012427
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • De Wolf, Katrien
  • Rottey, Sylvie
  • Vermaelen, Karim
  • Decaestecker, Karel
  • Sundahl, Nora
  • De Lobel, Lizzy
  • Goetghebeur, Els
  • De Meerleer, Gert
  • Lumen, Nicolaas
  • Fonteyne, Valerie
  • De Maeseneer, Daan
  • Ost, Piet
  • SpringerLink (Online service)

Other Objects (12)

Radiation treatment planning with embedded dose escalation

Radiation treatment planning with embedded dose escalation

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Dose escalation of a curcuminoid formulation

Dose escalation of a curcuminoid formulation

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

Radiation dose quantities

zweidimensionales bewegtes Bild

Radiation dose quantities

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Radiation : doses, effects, risk

Radiation : doses, effects, risk

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer

Related objects